Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives

Author's Avatar
Apr 12, 2019
Article's Main Image

LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and pet health industries, announced that is has retained the Emmes Group to assist with the development and execution of the Company's partnership and technology licensing initiatives and strategies.